Impact of onychomycosis on quality of life

Journal of the American Podiatric Medical Association

Volumn 87, Issue 11, 1997, Pages 507-511

  Drake, Lynn A ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; FEMALE; HAND DISEASE; HUMAN; MALE; ONYCHOMYCOSIS; QUALITY OF LIFE; REVIEW; SKIN DISEASE;

ADULT; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; ONYCHOMYCOSIS; QUALITY OF LIFE;

EID: 0031280058     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-87-11-507     Document Type: Article

References (31)

1. SCHER RK: Onychomycosis: a significant medical disorder. J Am Acad Dermatol 35: S2, 1996.
2. AMERICAN ACADEMY OF DERMATOLOGY GUIDELINES/OUTCOMES COMMITTEE: Guidelines of care for superficial mycotic infections of the skin: onychomycosis. J Am Acad Dermatol 34: 116, 1996.
3. SCHER RK: Onychomycosis is more than a cosmetic problem. Br J Dermatol 130 (suppl 43): 15, 1994.
4. CLARK WH JR: "The Skin," in Pathology, ed by E Rubin, J Farber, p 1196, JB Lippincott, Philadelphia, 1988.
5. LERNER RM, LERNER JV: Effect of age, sex, and physical attractiveness on child-peer relations, academic performance, and elementary school adjustment. Dev Psychol 13: 585, 1977.
6. MATHES EW, KAHN A: Physical attractiveness, happiness, neuroticism, and self-esteem. J Psychol 90: 27, 1975.
7. SHARPE M, MAYOU R, SEAGROATT V, ET AL: Why do doctors find some patients difficult to help? Q J Med 87: 187, 1994.
8. VAN DER DONK J, HUNFELD JAM, PASSCHIER J, ET AL: Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Soc Sci Med 38: 159, 1994.
9. JOWETT S, RYAN T: Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 20: 425, 1985.
10. DRAKE L: Quality of life issues for patients with fungal nail infections. AIDS Patient Care 9 (suppl 1): S15, 1995.
11. FINLAY AY, COLES EC: The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 132: 236, 1995.
12. LAMBERG L: Dermatologic disorders diminish quality of life. JAMA 277: 1663, 1997.
13. GONZÁLEZ-SERVA A: "Structure and Function," in Nails: Therapy, Diagnosis, Surgery, ed by RK Scher, CR Daniel III, WB Saunders, Philadelphia, 1990.
14. GRUSECK E, ABECK D, RING J: Relapsing severe Trichophyton rubrum infections in an immunocompromised host: evidence of onychomycosis as a source of reinfection based on lectin typing. Mycoses 36: 275, 1993.
15. RICH P: Special patient populations: onychomycosis in the diabetic patient. J Am Acad Dermatol 35: S10, 1996.
16. BERGFELD W, DANIEL CR III, DRAKE LA, ET AL: Superficial fungal infections: focus on diagnosis, treatment, and quality of life. Clinical Courier CME Program 14: 1,1996.
17. Quality of life and clinical trials [editorial]. Lancet 346: 1, 1995.
18. JENKINS CD: Assessment of outcomes of health intervention. Soc Sci Med 35: 367, 1992.
19. BARNETT DB: Assessment of quality of life. Am J Cardiol 67: 41C, 1991.
20. GILL TM, FEINSTEIN AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 272: 619, 1994.
21. GRADY KL: Quality of life in patients with chronic heart failure. Crit Care Nurs Clin North Am 5: 661, 1993.
22. SCHIPPER H, CLINCH J, POWELL V: "Definitions and Conceptual Issues," in Quality of Life Assessments in Clinical Trials, ed by B Spilker, Raven Press, New York, 1990.
23. BAROFSKY I, COHEN SJ, SUGARBAKER PH: "Selecting a Quality of Life Assessment Instrument: Standardized Tests, Clinical Assessments, or Custom-Designed Instruments," in Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies, ed by NK Wenger, ME Mattson, CD Furberg, et al, Le Jacq Publishing, New York, 1984.
24. LUBECK DP, PATRICK DL, MCNULTY P, ET AL: Quality of life of persons with onychomycosis. Qual Life Res 2: 341, 1993.
25. ASSAF RR, WEIL ML, BUCHHOLZ MA, ET AL: Patients' perceptions on the effects of nail disease on their quality of life [abstract]. International Summit on Cutaneous Antifungal Therapy, Boston, MA, November 10-13, 1994.
26. HONG JJ, STILLER MJ, MENN E, ET AL: A pilot study to determine the biopsychosocial effects of onychomycosis on a northeastern American sub-population [abstract]. J Invest Dermatol 104: 668, 1995.
27. OPP K: Patients' feelings and attitudes about their nail conditions. AIDS Patient Care 9 (suppl 1): S18, 1995.
28. GUPTA AK, SCHER RK, DE DONCKER P: Current management of onychomycosis: an overview. Dermatol Clin 15: 121, 1997.
29. MARCHETTI A, PIECH CT, MCGHAN WF, ET AL: Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model. Clin Ther 18: 757, 1996.
30. ARIKIAN SR, EINARSON TR, KOBELT-NGUYEN G, ET AL: A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. Br J Dermatol 130 (suppl 43): 35, 1994.
31. SCHER RK, TULUMBAS B, ARGO LF, ET AL: The nurse's role in diagnosing and treating onychomycosis. Dermatol Nurs 7: 335, 1995.